Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia
NCT03566394Phase 3Unknown
- Sponsor
- BC Cancer
- Start
- Jul 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of gabapentin in Arthralgia and myalgia syndrome (AMS), sponsored by BC Cancer. Status: unknown.
02
Drugs
gabapentin
03
Conditions
Arthralgia and myalgia syndrome (AMS)
Beyond the preview
Go deeper on NCT03566394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03566394.